Delivery Order SPE2DR25D1205-SPE2DR26F0VY5
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $66,046.37 on September 29, 2025, for the supply of Citalopram HBR 20 mg tablets in quantities of 500. The contract employs firm fixed pricing and is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award, indicating the contract was competitively awarded to the vendor through open...
- The Defense Logistics Agency awarded a $6,948.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count). This competitive award utilizes firm fixed pricing with a completion date of September 8, 2025, and represents a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 10 mg tablets (500 count) valued at $46,580.81 under a firm fixed-price contract. This competitively awarded delivery order, with no set-aside designation, was issued on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) with a ceiling value of $1,733.43. This competitive award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The contract is performed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $27,768.05 delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Citalopram HBr 20 mg tablets (500-count) with a ceiling value of $3,132.17. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by August 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $27,356.67 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units. This firm fixed-price, competitively awarded delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VY5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,494.09 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This contract was awarded on a firm fixed price basis with no set-aside designation, indicating open competition among qualified vendors. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The citalopram tablets awarded under this delivery order support mental health treatment requirements across the Defense Health Agency and other government healthcare systems served through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 10/29/25 |